KMDA
Price
$6.50
Change
+$0.15 (+2.36%)
Updated
Apr 17 closing price
Capitalization
306.49M
37 days until earnings call
RGC
Price
$29.12
Change
+$1.87 (+6.86%)
Updated
Apr 17 closing price
Capitalization
50.75M
Ad is loading...

KMDA vs RGC

Header iconKMDA vs RGC Comparison
Open Charts KMDA vs RGCBanner chart's image
Kamada
Price$6.50
Change+$0.15 (+2.36%)
Volume$97.48K
Capitalization306.49M
Regencell Bioscience Holdings
Price$29.12
Change+$1.87 (+6.86%)
Volume$18.75K
Capitalization50.75M
KMDA vs RGC Comparison Chart
Loading...
KMDA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RGC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
KMDA vs. RGC commentary
Apr 20, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is KMDA is a Hold and RGC is a Hold.

Ad is loading...
COMPARISON
Comparison
Apr 20, 2025
Stock price -- (KMDA: $6.50 vs. RGC: $29.12)
Brand notoriety: KMDA and RGC are both not notable
Both companies represent the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: KMDA: 55% vs. RGC: 2%
Market capitalization -- KMDA: $306.49M vs. RGC: $50.75M
KMDA [@Pharmaceuticals: Other] is valued at $306.49M. RGC’s [@Pharmaceuticals: Other] market capitalization is $50.75M. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $77.48B to $0. The average market capitalization across the [@Pharmaceuticals: Other] industry is $3.63B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

KMDA’s FA Score shows that 0 FA rating(s) are green whileRGC’s FA Score has 0 green FA rating(s).

  • KMDA’s FA Score: 0 green, 5 red.
  • RGC’s FA Score: 0 green, 5 red.
According to our system of comparison, both KMDA and RGC are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

KMDA’s TA Score shows that 5 TA indicator(s) are bullish while RGC’s TA Score has 7 bullish TA indicator(s).

  • KMDA’s TA Score: 5 bullish, 4 bearish.
  • RGC’s TA Score: 7 bullish, 4 bearish.
According to our system of comparison, RGC is a better buy in the short-term than KMDA.

Price Growth

KMDA (@Pharmaceuticals: Other) experienced а +9.98% price change this week, while RGC (@Pharmaceuticals: Other) price change was +3.12% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was +3.78%. For the same industry, the average monthly price growth was -5.82%, and the average quarterly price growth was -13.07%.

Reported Earning Dates

KMDA is expected to report earnings on Aug 13, 2025.

RGC is expected to report earnings on Oct 31, 2022.

Industries' Descriptions

@Pharmaceuticals: Other (+3.78% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
KMDA($306M) has a higher market cap than RGC($50.8M). RGC YTD gains are higher at: 489.474 vs. KMDA (9.791). KMDA has higher annual earnings (EBITDA): 22.4M vs. RGC (-4.67M). KMDA has more cash in the bank: 55.6M vs. RGC (306K). RGC has less debt than KMDA: RGC (3.54M) vs KMDA (8.82M). KMDA has higher revenues than RGC: KMDA (143M) vs RGC (0).
KMDARGCKMDA / RGC
Capitalization306M50.8M602%
EBITDA22.4M-4.67M-479%
Gain YTD9.791489.4742%
P/E Ratio37.43N/A-
Revenue143M0-
Total Cash55.6M306K18,170%
Total Debt8.82M3.54M249%
FUNDAMENTALS RATINGS
KMDA vs RGC: Fundamental Ratings
KMDA
RGC
OUTLOOK RATING
1..100
5050
VALUATION
overvalued / fair valued / undervalued
1..100
74
Overvalued
83
Overvalued
PROFIT vs RISK RATING
1..100
84100
SMR RATING
1..100
82100
PRICE GROWTH RATING
1..100
4634
P/E GROWTH RATING
1..100
72100
SEASONALITY SCORE
1..100
5050

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

KMDA's Valuation (74) in the Biotechnology industry is in the same range as RGC (83) in the Movies Or Entertainment industry. This means that KMDA’s stock grew similarly to RGC’s over the last 12 months.

KMDA's Profit vs Risk Rating (84) in the Biotechnology industry is in the same range as RGC (100) in the Movies Or Entertainment industry. This means that KMDA’s stock grew similarly to RGC’s over the last 12 months.

KMDA's SMR Rating (82) in the Biotechnology industry is in the same range as RGC (100) in the Movies Or Entertainment industry. This means that KMDA’s stock grew similarly to RGC’s over the last 12 months.

RGC's Price Growth Rating (34) in the Movies Or Entertainment industry is in the same range as KMDA (46) in the Biotechnology industry. This means that RGC’s stock grew similarly to KMDA’s over the last 12 months.

KMDA's P/E Growth Rating (72) in the Biotechnology industry is in the same range as RGC (100) in the Movies Or Entertainment industry. This means that KMDA’s stock grew similarly to RGC’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
KMDARGC
RSI
ODDS (%)
Bullish Trend 4 days ago
84%
Bearish Trend 4 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 4 days ago
77%
Bullish Trend 4 days ago
88%
Momentum
ODDS (%)
Bullish Trend 4 days ago
69%
Bullish Trend 4 days ago
86%
MACD
ODDS (%)
Bullish Trend 4 days ago
73%
Bearish Trend 4 days ago
90%
TrendWeek
ODDS (%)
Bullish Trend 4 days ago
65%
Bullish Trend 4 days ago
80%
TrendMonth
ODDS (%)
Bearish Trend 4 days ago
68%
Bearish Trend 4 days ago
89%
Advances
ODDS (%)
Bullish Trend 4 days ago
68%
Bullish Trend 17 days ago
83%
Declines
ODDS (%)
Bearish Trend 13 days ago
66%
Bearish Trend 5 days ago
89%
BollingerBands
ODDS (%)
Bullish Trend 4 days ago
90%
Bearish Trend 7 days ago
90%
Aroon
ODDS (%)
Bearish Trend 4 days ago
68%
Bullish Trend 4 days ago
83%
View a ticker or compare two or three
Ad is loading...
KMDA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RGC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GME26.780.53
+2.02%
GameStop Corp
AAPL196.982.71
+1.39%
Apple
BTC.X85063.414000612.609400
+0.73%
Bitcoin cryptocurrency
SPY525.66N/A
N/A
SPDR® S&P 500® ETF
TSLA241.37-0.18
-0.07%
Tesla

KMDA and

Correlation & Price change

A.I.dvisor tells us that KMDA and RDY have been poorly correlated (+28% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that KMDA and RDY's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To KMDA
1D Price
Change %
KMDA100%
+2.36%
RDY - KMDA
28%
Poorly correlated
+1.71%
OGI - KMDA
26%
Poorly correlated
+2.88%
SCYX - KMDA
23%
Poorly correlated
-0.91%
ESPR - KMDA
22%
Poorly correlated
N/A
ASRT - KMDA
22%
Poorly correlated
-1.72%
More

RGC and

Correlation & Price change

A.I.dvisor tells us that RGC and CLCFF have been poorly correlated (+21% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that RGC and CLCFF's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RGC
1D Price
Change %
RGC100%
+6.86%
CLCFF - RGC
21%
Poorly correlated
N/A
QNTM - RGC
21%
Poorly correlated
+0.96%
SBFM - RGC
20%
Poorly correlated
+2.46%
RDY - RGC
8%
Poorly correlated
+1.71%
KMDA - RGC
6%
Poorly correlated
+2.36%
More